Skip to content

Development of early diagostic kit for breast cancer

Development of early diagnostic kit for brast cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-08000163
Enrollment
Unknown
Registered
2008-10-13
Start date
2007-10-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:
Index test:

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with breast cancer without chemotherapy or radiotherapy,patients with breast hyperplasia, health women

Exclusion criteria

Exclusion criteria: patients with breast cancer after chemotherapy or radiotherapy

Design outcomes

Primary

MeasureTime frame
leveles of serum EEC;

Secondary

MeasureTime frame
protein expression leveles of EECP of tumor tissue;

Countries

China

Contacts

Public ContactHong Zheng
hongzheng@gmail.com+86 028 81812830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026